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Abstract: The crystallization process of a bioactive sil-
icate glass with 47.5SiO2-10Na2O-10K2O-10MgO-20CaO-
2.5P2O5 molar composition was investigated by using non-
isothermal differential t hermal a nalysis ( DTA). The DTA 
plots recorded at different heating rates exhibited a single 
crystallization peak. The activation energy for crystalliza-
tion was estimated by applying the equations proposed by 
Kissinger and Matusita-Sakka. The Johnson-Mehl-Avrami 
exponent (n) was assessed by using the Ozawa and Augis-
Bennett methods. The analyses suggest that a surface 
crystallization mechanism with one-dimensional crystal 
growth is predominant. The activation energy for viscous 
flow was also assessed (176 kJ/mol) and was found lower 
than the activation energy for crystallization (271 kJ/mol). 
This confirms the stability of 47.5B against crystallization 
and its good sinterability, which is a highly attractive fea-
ture for producing glass products of biomedical interest, 
such as bioactive porous scaffolds for bone repair.
Keywords: Bioactive glass; Glass-ceramic; Thermal analy-
sis; Crystallization
1 Introduction
Bioactive glasses were invented fifty years ago at the Uni-
versity of Florida by Prof. Larry Hench and his team, who 
developed the famous 45S5 composition (45SiO2-24.5CaO-
24.5Na2O-6P2O5 wt.%) [1]. This glass, trade-named as
*Corresponding Author: Francesco Baino: Institute of Ma-
terials Physics and Engineering, Applied Science and Tech-
nology Department, Politecnico di Torino, Corso Duca degli
Abruzzi 24, 10129 Torino, Italy; Email: francesco.baino@polito.it;
Tel.: +39 011 090 4668; Fax: +39 011 090 4624
Elisa Fiume, Enrica Verné: Institute of Materials Physics and Engi-
neering, Applied Science and Technology Department, Politecnico
di Torino, Corso Duca degli Abruzzi 24, 10129 Torino, Italy
Bioglassr, was initially found able to bond both to bone
and to soft collagenous tissues of the body [2]. Hence, it
was soon considered an excellent biomaterial to repair
bone tissue undergoing injury or dysfunctionality and, to
date, it has been implanted in more than 1.5 million pa-
tients suffering from osseous defects in orthopedic and
dental applications [3]. Recent studies carried out over
the past two decades have also revealed additional highly-
appealing properties of 45S5 Bioglassr, including an in-
herent antibacterial effect due to the release of alkaline
ions (Ca2+ and Na+) [4, 5] and the capability to stimulate
angiogenesis, which is the key to accelerate wound heal-
ing process [6, 7].
The main drawback of 45S5 Bioglassr concerns its
poor workability: in fact, the glass transition temperature
(Tg) and the onset of crystallization (Tx) are very close,
thus limiting the possibility of sintering by viscous flow [8].
As a result, 45S5 glass cannot be sintered without under-
going devitrification, which has an impact on the kinetics
of apatite formation (bioactivity) in vitro and in vivo and,
hence, on the bone-bonding capability and osteointegra-
tion rate. In this regard, Peitl et al. [9] showed that the on-
set time of hydroxyapatite formation on the surface of 45S5
Bioglassr increases from 8 to 25 h when the crystalline
fraction increases from 0 to 60%; however, the bioactiv-
ity is not totally suppressed and the partially-crystallized
material is still potentially suitable for biomedical applica-
tions [10–12]. A similar behavior was also found to occur
in other silicate (e.g. S53P4, 53SiO2-20CaO-23Na2O-4P2O5
wt.% [13]) and phosphate glasses (50P2O5-(40 – x)CaO-
xSrO-10Na2O with x = 0, 20, and 40 mol.%) [14]. Over the
years, other glasses have been developed with a larger
sintering window (e.g. 13-93, 53SiO2-6Na2O-12K2O-5MgO-
20CaO-4P2O5 wt.%) [15] and/or with the capability of re-
taining an excellent and fast apatite-forming ability also in
partially-crystallized forms (e.g. CEL2, 43.8SiO2-15.0Na2O-
6.1K2O-4.6MgO-23.6CaO-6.9P2O5 wt.%) [16].
The fabrication of sintered bioactive glass products,
such as three-dimensional macroporous scaffolds, is of-
ten a challenge because, on one hand, extensive densifica-
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tion is required to achieve enough strength for the glass-
derived product to be safely handled and, on the other
hand, crystallization of the glass, which could negatively
affect the bioactivity, may occur prior to significant densi-
fication.
Amorphous scaffolds made of sintered 13-93 glass
were reported to have suitable mechanical properties for
bone repair applications, but their apatite-forming ability
was lower compared to 45S5 composition [17]. A compara-
tive study between CEL2- and 45S5-derived glass-ceramic
foams suggested that the apatite-forming kinetics of the
former are faster, leading to a thicker surface layer of hy-
droxyapatite [18].
Verné et al. developed a silicate glass (47.5B) with an
exceptionally large sinterability range (Tx − Tg = 260∘C)
and retaining in vitro bioactivity after partial devitrifica-
tion at 800∘C for 3 h [19]. These properties suggest the
potential suitability of such a material for making bioac-
tive porous scaffolds; however, the crystallization behav-
ior should be determined first. In this regard, the present
work aims at investigating the crystallization mechanism
of 47.5B glass powder under non-isothermal conditions in
order to assess the activation energies for crystallization
and viscous flow. These parameters have not been deter-
mined for such glass composition so far. Over the past
half century, anumber of approacheshavebeendeveloped
to estimate the activation energy for crystallization [20],
but there is a paucity of relevant studies about biomed-
ical glasses. Of those, the vast majority focused on 45S5
Bioglassr [21, 22], while almost no information have been
provided on other bioactive glass systems.
2 Materials and methods
2.1 Glass preparation
The analyzed material was a glass (47.5B) originally de-
veloped by Verné et al. [19] at Politecnico di Torino
in the composition 47.5SiO2-10Na2O-10K2O-10MgO-20CaO-
2.5P2O5 (mol.%) and was produced using a standard
melting method in a platinum crucible. The raw pre-
cursors (SiO2, Na2CO3, K2CO3, (MgCO3)4·Mg(OH)2·5H2O,
CaCO3 and Ca3(PO4)2 high-purity powders purchased
from Sigma-Aldrich) were homogeneously mixed in the
crucible and melted in air at 1500∘C for 0.5 h; the melt
was then quenched in deionized water to produce a frit
that was ball milled (Pulverisette 0, Frtisch, Germany) and
sievedbelow32 µmbya stainless steel sieve (Giuliani Tech-
nologies Srl, Torino, Italy). According to the authors’ previ-
ous experience on other glass compositions, this particle
size range is very suitable to produce porous glass-derived
scaffolds by various technologies, including foam replica-
tion and robocasting; this is the reason why the glass crys-
tallization behavior was studied using 47.5B powder with
such size.
2.2 Thermal properties
The glass transition temperature (Tg) and the peak crys-
tallization temperature (Tp) were determined by differen-
tial thermal analysis (DTA; DTA404PC, Netzsch, Germany)
at various heating rates β (10, 20, 30 and 40∘C/min). The
measurements were performed on 50 mg of glass that was
heated to 1200∘C in a platinum crucible under nitrogen
flow (inert atmosphere) using Al2O3 powder as a reference
material. The glass transition temperaturewasdetermined
at the inflection point of the DTA curve, as obtained from
the first derivative of the thermal plot. The peak crystal-
lization temperature was found at the maximum of the
exothermic peak. The accuracy of the measurements was
± 3∘C.
2.3 Analysis of the crystallization process
The crystallization process in glasses is usually described
by two parameters, i.e. the Johnson-Mehl-Avrami (JMA) co-
efficient (n) – which depends on the mechanism of crystal
nucleation and growth [23, 24] – and the activation energy
for crystallization.
The JMA coefficient was quantified by suing two inde-
pendent techniques. First, it was determined by theOzawa
equation [25]:
−n = d (ln (− ln (1 − χ)))d(ln β)
⃒⃒⃒⃒
T
(1)
where χ is the volume fraction of crystallized phase at a
fixed temperature T. The values of χ were estimated from
the DTA plots as the ratio between the partial area under
the exothermic peak (at a chosen temperature) and the to-
tal area under the peak. A plot of ln (− ln (1 − χ)) vs. ln β,
followed by linear interpolation, gives a straight line of
slope n. The value of the JMA parameter n was calculated
as mean ± SD of the slopes of the plots.
The coefficient n was also estimated by using the
Augis-Bennet method [26]:
n = 2.5RT
2
p
∆TFWHMEc
(2)
where ∆TFWHM is the full width of the DTA exothermic
peak at the halfmaximum. In this case, the JMAparameter
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was calculated asmean ± SD of the n-values determined at
each heating rate (β).
The activation energy for crystallization can be as-
sessed from non-isothermal DTA data by applying mod-
els that relate the variation of Tp to the heating rate β.
Kissinger proposed the following equation to estimate the
crystallization activation energy (Ec,K) [27]:
ln βT2p
= −Ec,KRTp
+ constant (3)
A plot of ln βT2p vs.
1
Tp , followed by linear interpolation,
gives a straight line of slope Ec,KR (R = 8.314 J/mol K is the
ideal gas constant), from which Ec,K can be easily calcu-
lated.
However, Matusita et al. [28] demonstrated that Equa-
tion (3) is valid only when crystal growth occurs on a fixed
number of nuclei. Hence, the Kissinger model yields an
underestimated value of the activation energy for crystal-
lization if most nuclei are formed during the DTAmeasure-
ment, as the number of nucleimay varywith β. Amore gen-
eral equation deriving from the Kissinger model was then
proposed by Matusita and Sakka [29]:
ln β
n
T2p
= −mEcRTp
+ constant (4)
where Ec is the correct activation energy for crystallization,
n is the JMA exponent and m is a numerical factor which
depends on the dimensionality of crystal growth, i.e. three-
dimensional sphere-like (m = 3), two-dimensional plate-
like (m = 2) or one-dimensional rod-like (m = 1) crystalliza-
tion [30]. A plot of ln β
n
T2p
vs. 1Tp , followed by linear interpo-
lation, gives a straight line of slope mEcR , fromwhich Ec can
be calculated.
As a general rule, we have m ≈ 1 when surface crys-
tallization predominates, whereas m ≈ 3 when bulk crys-
tallization is predominant. The value of m is related to n
as m = n – 1 when crystal nucleation occurs during DTA.
When a surface crystallization mechanism is dominant,
we have m = n = 1 regardless of whether nuclei are formed
prior to or during thermal analysis: in this case, Matusita-
Sakka equation (Equation (4)) essentially reduces to the
Kissinger one (Equation (3), i.e. Ec = EcK [30].
The activation energy for viscous flow (Evf ) was esti-
mated by following the approach proposed by Francis et
al. [31] who suggested the application of a Kissinger-type
model. Thus, a plot of ln βT2g vs.
1
Tg , followed by linear inter-
polation, gives a straight line of slope EvfR , from which Evf
can be easily calculated.
The validity of the JMA model was discussed by us-
ing the method proposed by Malek [24]. He showed that,
for the model to be applicable, the crystallization rate dχdt
must depend only on the fraction χ of the glass crystallized
and the temperature T, i.e. the thermal history of the ma-
terial must not affect the crystallization mechanism. This
validity test is based on the analysis of a probe function
z(χ) ∝ dχdt , which in non-isothermal conditions is defined
as:
z (χ) = ϕT2 (5)
where ϕ is the specific heat flow.
According to the Equation (5), the function z(χ) does
not depend on kinetic parameters, and the JMA model is
valid if the maximum of z(χ) is located at χ = 0.63 ± 0.02
[32].
3 Results and discussion
Figure 1 shows the DTA plots of 47.5B glass powder at dif-
ferent heating rates. A single exothermic peak of crystal-
lization was recorded, which is consistent with previous
investigations on this glass system [19]. The glass tran-
sition and peak crystallization temperatures can be ob-
served to increase as the heating rate β increases from 10
to 40∘C/min. Specifically, Tg and Tp vary within 527-567∘C
and 765-848∘C, respectively.
The JMA coefficient n was initially calculated from the
Ozawa plots at five different temperatures (770, 780, 790,
800 and 810∘C) (Figure 2) and found equal to 1.4 ± 0.03.
Assessment of n by the Augis-Bennet method yielded the
value 1.8 ± 0.2, which is comparable to the Ozawa’s one.
Figure 3 shows the Kissinger plot for the calculation
of Ec,K; the least squares fitting yielded an apparent ac-
tivation energy for crystallization of 131 kJ/mol. However,
since both the Ozawamodel and the Augis-Bennetmethod
yield a value of n > 1, the application of the Kissinger equa-
tion is not appropriate and could lead to an underestima-
tion of the activation energy. As the crystal growth dimen-
sionality m can be calculated as n – 1 in the case of a non-
constant number of nuclei, which happens during theDTA
experiments while crystal nucleation occurs, we can as-
sume thatm is approximately equal to 1 [33, 34]. This value
indicates that surface crystallization is dominantwith one-
dimensional rod-like crystallization in 47.5B glass parti-
cles. Once the values of n andm have been calculated, it is
possible to apply the equation proposed by Matusita and
Sakka (Equation (4)) [29] to calculate the activation energy
for crystallization in a more reliable way as compared to
the Kissinger model. The relevant plot is reported in Fig-
ure 4 and yielded an energy value Ec of 251 kJ/mol (> Ec,K).
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Figure 1: DTA thermographs of 47.5B glass powders collected at
different heating rates (β).
Figure 2: Plots in accordance with the Ozawa equation to determine
the JMA parameter (n).
Erol et al. [35] suggested a simplified approach to cal-
culate Ec starting from the (incorrect) value of Ec,K when
m ≠ n ≠ 1. Equations (3) and (4) can be combined together
to obtain the following formula:
Ec = nmEc,K − 2
n − 1
m RTp (6)
As the condition Ec >> 20RTp is verified inmost oxide glass
systems [36], the term2 n−1m RTp in Equation (6) canbe elim-
inated introducing an error of less than 10% in the value of
Figure 3: Plot in accordance with the Kissinger equation to deter-
mine the apparent activation energy for crystallization (EcK ).
Figure 4: Plot in accordance with the Matusita and Sakka equation
to determine the correct activation energy for crystallization (Ec).
Ec. Hence, the following simple relation can be obtained:
Ec ≈ nmEc,K (7)
The activation energy for crystallization obtained by Equa-
tion (7) is 236 kJ/mol, which actually differs by only 6.4 %
from the value assessed by Matusita-Sakka interpolation
(251 kJ/mol) (Figure 4).
It is interesting to observe that the value of Ec for 47.5B
glass powder assessed in this study is lower than that ob-
served for powder of classical 45S5 Bioglassr with the
sameparticle size range below32 µm(e.g. 311 kJ/mol in [37]
and 381-399 kJ/mol in [22]); a comparison of the relevant
parameters is shown in Table 1. This depends on the dif-
ferent glass formulations and, hence, on the bonding en-
ergies involved. Because of the high bonding strengths of
Si–O and P–O bonds, it is unlikely that a significant num-
ber of these bonds is broken during devitrification; rather,
as suggested by Clupper and Hench [21], crystallization is
expected to involve the breaking of modifier–O bonds that
may have bonding strengths lower than Ec. In particular,
K–O bonds having a significantly low bonding energy [38]
are present in 47.5B glass and absent in 45S5 Bioglassr,
which suggests that the former may require a compara-
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Table 1: Thermal and kinetic parameters of 47.B and 45S5 Bioglassr particles.
Glass powder (<32 µm) n m Ec (kJ/mol) Evf (kJ/mol) KH a
47.5B 1.4-1.8 1 251 181 0.40
45S5 Bioglassr 1 [22, 37] 1 [22, 37] 311 [37], 381-399 [22] 338 [37] 0.066 [16]
a The Hruby parameter was determined using a heating rate β = 20 ∘C/min in the DTA experiment, with Tg = 542∘C, Tx = 670∘C and Tm = 990∘C.
tively lower activation energy for crystallization. Further-
more, it is worth observing that the crystalline phases
formed during devitrification of the two materials are dif-
ferent, and this could also justify the different values of
Ec. In fact, 47.5B tends to crystallize to Na2CaSi3O8 after
thermal treatment at 800∘C [19], whereas other phases
were reported to develop in 45S5 Bioglassr. In this re-
gard, phase assignment of crystallized 45S5 Bioglassr is
not unanimous. Over the years, different research groups
suggested different possible scenarios, i.e. crystallization
of Na2Ca2Si3O9 [9, 21] or Na2CaSi2O6 [8, 15] as the main
phase, with the optional presence of Na2Ca4(PO4)2SiO4
(silicorhenanite) as a secondary phase [39]. In the attempt
to solve this controversy Bellucci et al. [40] hypothesized
the coexistence of Na2Ca2Si3O9and Na2CaSi2O6, but this
topic is still under debate.
It is also interesting to highlight that previous SEM ob-
servations on partially-devitrified 47.5B glass revealed the
needle-likemorphologyofNa2CaSi3O8 crystals [19],which
is in agreement with the dimensionality of crystal growth
(m = 1, one-dimensional rod-like) assessed in this work.
The Kissinger-type plot used for estimating the vis-
cous flow activation energy is shown in Figure 5 and the
least squares interpolation yields a value of 181 kJ/mol.
Evf is lower than Ec, showing that the energy needed for
viscous flow to occur is lower than that required for dif-
fusion to progress the crystallization. This confirms that
47.5B glass exhibits a higher stability against crystalliza-
tion as compared to 45S5 Bioglassr, which conversely has
Ec < Evf (Table 1) and a rapid tendency to crystallize just
above Tg [37].
This behavior can be further quantified by calculating
the Hruby parameter that is defined as follows [41]:
KH =
Tx − Tg
Tm − Tx
(8)
where Tx is the onset of crystallization and Tm the melting
temperature determined from DTA plot.
The Hruby parameter KH serves as a measure of the
glass stability against crystallization: the larger KH of a cer-
tain glass, the greater its stability against crystallization
upon heating [42]. As shown in Table 1, the Hruby param-
eter of 47.5B glass (0.40) is six times higher than that cal-
Figure 5: Kissinger-type plot for the determination of the activation
energy for the viscous flow (Evf ).
Figure 6: Plots of the normalized z(χ) functions (Malek test).
culated for 45S5 Bioglassr powder (0.066) [16] under the
same experimental conditions.
The JMA model validity was assessed by applying the
method proposed by Malek [24]. The normalized z(χ) func-
tions, reported in Figure 6, have a typical bell-type shape
and their maximum varies from 0.40 to 0.48 as the hating
rate β increases from 10 to 40∘C/min. Therefore, the crys-
tallization process of 47.5B bioactive glass can be just ap-
proximately described by the JMA model, which is valid
only if the maximum of the z(χ) function is located at χ =
0.63 ± 0.02 [32]. This suggests that the crystallizationmech-
anism in 47.5B glass ismore complex than a simple process
of crystal nucleation and growth and may also change as
a function of the heating rate. Future investigations could
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be addressed to elucidate whether, for example, glass-in-
glass phase separation takes place during the crystalliza-
tion of 47.5B, as observed in other bioactive glass systems
such as 45S5 Bioglassr [8, 22, 43].
4 Conclusions
This work investigated the crystallization process of a
SiO2–P2O5–CaO–MgO–Na2O–K2O bioactive glass under
non-isothermal conditions. The analyses gave evidence
of a complex crystallization process where surface crys-
tallization associated to the development of rod-like crys-
tals was dominant. The activation energy for viscous flow
was found lower than that required for crystallization,
which suggests the capability of this glass to achieve sig-
nificant densification before crystallization begins when
it is thermally-treated above Tg. From a methodological
viewpoint, this study also demonstrates that using multi-
ple and complementarymethods, i.e. theOzawaandAugis-
Bennet methods for determining the JMA exponent n as
well as the Kissinger and Matusita-Sakka equations for as-
sessing the crystallization activation energy, is fundamen-
tal to accurately describe the crystallization parameters.
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